P619: TRACKING DISEASE PARAMETERS BY MRD, CT AND PET IN FIRST LINE CLL PATIENTS TREATED WITH FIXED DURATION IBRUTINIB-VENETOCLAX; INTERIM ANALYSIS OF THE FIRST 30 PATIENTS IN HOVON 158/NEXT STEP TRIAL.

• Sabina Kersting,
• Mark-David Levin,
• Julie Dubois,
• Yvette van Norden,
• Johan Dobber,
• Yvonne Jauw,
• Anne-Marie van der Kevie-Kersemaekers,
• Clemens Mellink,
• Caspar Da Cunha-Bang,
• Leonie Van Desr Burg,
• Doreen Te Raa,
• Fransien de Boer,
• Jolanda Droogendijk,
• Cecile Idink,
• Koen De Heer,
• Marten Nijziel,
• Lidwine Tick,
• Inge Ludwig,
• Mathijs Silbermann,
• Aart Beeker,
• Mar Bellido,
• Ludo Evers,
• Gerben Zwezerijnen,
• Josée Zijlstra,
• Marcel Kap,
• Carsten Niemann,
• Arnon Kater

Affiliations

Sabina Kersting

1 Department of Hematology, Haga Teaching Hospital, Den Haag, The Netherlands

Mark-David Levin

2 Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands

Julie Dubois

3 Department of hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands

Yvette van Norden

4 Department of Hematology, HOVON Data Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands

Johan Dobber

5 Laboratory of Hematology, Amterdam University Medical Centers,, Amsterdam, The Netherlands

Yvonne Jauw

3 Department of hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands

Anne-Marie van der Kevie-Kersemaekers

6 Department of Human Genetics, Amsterdam Universitiy Medical Centers, Amsterdam, The Netherlands

Clemens Mellink

6 Department of Human Genetics, Amsterdam Universitiy Medical Centers, Amsterdam, The Netherlands

Caspar Da Cunha-Bang

7 Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

Leonie Van Desr Burg

8 Department of Internal Medicine, Antonius Hospital Sneek, Sneek, The Netherlands

Doreen Te Raa

9 Department of Internal Medicin, Gelderland Valley Hospital, Ede, The Netherlands

Fransien de Boer

10 Department of Internal Medicine, Ikazia Hospital, Rotterdam, The Netherlands

Jolanda Droogendijk

11 Department of Internal Medicine, Elisabeth Tweesteden Ziekenhuis, Tilburg, The Netherlands

Cecile Idink

12 Department of Internal Medicin, ZorgSaam Hospital Terneuzen, Terneuzen, The Netherlands

Koen De Heer

13 Department of Internal Medicine, Flevohospital, Almere, The Netherlands

Marten Nijziel

14 Catharine Cancer Institute, Eindhoven, The Netherlands

Lidwine Tick

15 Department of Internal Medicine, Maxima Medical Center, Veldhoven, The Netherlands

Inge Ludwig

16 Department of Internal Medicin, Bernhove Hospital, Uden, The Netherlands

Mathijs Silbermann

17 Department of Internal Medicin, Ter Gooi Hospital, Hilversum, The Netherlands

Aart Beeker

18 Department of Internal Medicine, Spaarne Gasthuis, Hoofddorp, The Netherlands

Mar Bellido

19 Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands

Ludo Evers

5 Laboratory of Hematology, Amterdam University Medical Centers,, Amsterdam, The Netherlands

Gerben Zwezerijnen

20 Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands

Josée Zijlstra

3 Department of hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands

Marcel Kap

4 Department of Hematology, HOVON Data Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands

Carsten Niemann

21 Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, The Netherlands

Arnon Kater

3 Department of hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands